Translating the WHO 25×25 goals into a UK context: The PROMISE modelling study

BMJ Open

Volumn 7, Issue 4, 2017, Pages

  Cobiac, Linda J ^a,b   Scarborough, Peter ^b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CEREBROVASCULAR ACCIDENT; COUNSELING; DEMENTIA; DEPRESSION; DIABETES MELLITUS; HEALTH CARE COST; HEALTH SURVEY; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MORBIDITY; MORTALITY; NON COMMUNICABLE DISEASE; OBESITY; PHYSICAL ACTIVITY; PHYSICAL INACTIVITY; PREMATURE MORTALITY; PREVALENCE; RISK FACTOR; RISK REDUCTION; SALT INTAKE; SMOKING; SOCIAL CARE; TOBACCO USE; UNITED KINGDOM; WORLD HEALTH ORGANIZATION; ADULT; AGED; CAUSE OF DEATH; FEMALE; FORECASTING; MALE; MIDDLE AGED; MOTIVATION; RETROSPECTIVE STUDY; SURVIVAL RATE; THEORETICAL MODEL; TRENDS;

ADULT; AGED; CAUSE OF DEATH; FEMALE; FORECASTING; GOALS; HUMANS; MALE; MIDDLE AGED; MODELS, THEORETICAL; MORBIDITY; NONCOMMUNICABLE DISEASES; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; UNITED KINGDOM; WORLD HEALTH ORGANIZATION;

EID: 85017139349     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2016-012805     Document Type: Article

References (60)

1. United Nations. Political declaration of the high-level meeting of the General Assembly on the prevention and control of non-communicable diseases. United Nations General Assembly, Sixty-sixth session, Agenda item 117. 2011.
2. WHO. Global action plan for the prevention and control of noncommunicable diseases 2013-2020. Geneva: World Health Organization, 2013.
3. Kontis V, Mathers CD, Rehm J, et al. Contribution of six risk factors to achieving the 25×25 non-communicable disease mortality reduction target: a modelling study. Lancet 2014;384:427-37.
4. Beaglehole R, Bonita R, Ezzati M, et al. NCD Countdown 2025: accountability for the 25×25 NCD mortality reduction target. Lancet 2014;384:105-7.
5. Pearce N, Ebrahim S, McKee M, et al. The road to 25×25: how can the five-target strategy reach its goal? Lancet Glob Health 2014;2: e126-8.
6. WHO. Health in 2015: from MDGs, Millennium Development Goals to SDGs, Sustainable Development Goals. Geneva: World Health Organization, 2015.
7. The Richmond Group of Charities. (15 December 2015). http://www. richmondgroupofcharities.org.uk/
8. Joint Health Surveys Unit. Health Survey for England 2013 (and previous editions). Leeds: Health and Social Care Information Centre, 2014.
9. McPherson K, Marsh T, Brown M. Foresight. Tackling obesities-modelling future trends in obesity and the impact on health. London: Government Office for Science, 2007.
10. WHO. Noncommunicable diseases global monitoring framework: indicator definitions and specifications. Geneva: World Health Organization, 2014.
11. He FJ, Li J, MacGregor GA. Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials. BMJ 2013;346:f1325.
12. Baumgart M, Snyder HM, Carrillo MC, et al. Summary of the evidence on modifiable risk factors for cognitive decline and dementia: a population-based perspective. Alzheimers Dement 2015;11:718-26.
13. Valkanova V, Ebmeier KP. Vascular risk factors and depression in later life: a systematic review and meta-analysis. Biol Psychiatry 2013;73:406-13.
14. Cheng G, Huang C, Deng H, et al. Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies. Intern Med J 2012;42:484-91.
15. Lim S, Vos T, Flaxman A, et al. The burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions 1990-2010: a systematic analysis. Lancet 2013;380:2224-60.
16. Prospective Studies Collaboration. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 2009;373:1083-96.
17. Norat T, Aune D, Vieira R, et al. The associations between food, nutrition and physical activity and the risk of pancreatic cancer. WCRF/AICR Systematic Literature Review Continuous Update Project Report, 2011.
18. Luppino FS, de Wit LM, Bouvy PF, et al. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry 2010;67:220-9.
19. Beydoun M, Beydoun H, Wang Y. Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta-analysis. Obes Rev 2008;9:204-18.
20. Thun MJ, Apicella LF, Henley SJ. Smoking vs other risk factors as the cause of smoking-attributable deaths. Confounding in the courtroom. JAMA 2000;284:706-12.
21. Willi C, Bodenmann P, Ghali WA, et al. Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2007;298:2654-64.
22. Gandini S, Botteri E, Iodice S, et al. Tobacco smoking and cancer: a meta-analysis. Int J Cancer 2008;122:155-64.
23. Lee YCA, Cohet C, Yang YC, et al. Meta-analysis of epidemiologic studies on cigarette smoking and liver cancer. Int J Epidemiol 2009;38:1497-511.
24. Luger TM, Suls J, Vander Weg MW. How robust is the association between smoking and depression in adults? A meta-analysis using linear mixed-effects models. Addict Behav 2014;39:1418-29.
25. Zhong G, Wang Y, Zhang Y, et al. Smoking is associated with an increased risk of dementia: a meta-analysis of prospective cohort studies with investigation of potential effect modifiers. PLoS ONE 2015;10:e0118333.
26. Peters SA, Huxley RR, Woodward M. Diabetes as risk factor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858, 507 individuals and 28, 203 coronary events. Diabetologia 2014;57:1542-51.
27. Peters SA, Huxley RR, Woodward M. Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohorts, including 775 385 individuals and 12 539 strokes. Lancet 2014;383:1973-80.
28. Rotella F, Mannucci E. Diabetes mellitus as a risk factor for depression. A meta-analysis of longitudinal studies. Diabetes Res Clin Pract 2013;99:98-104.
29. Gudala K, Bansal D, Schifano F, et al. Diabetes mellitus and risk of dementia: a meta-analysis of prospective observational studies. J Diabetes Investig 2013;4:640-50.
30. Lewington S, Prospective studies collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies (vol 360, pg 1903, 2002). Lancet 2003;361:1060.
31. Shield KD, Parry C, Rehm J. Chronic diseases and conditions related to alcohol use. Alcohol Res 2014;35:155-73.
32. Patra J, Taylor B, Irving H, et al. Alcohol consumption and the risk of morbidity and mortality for different stroke types-a systematic review and meta-analysis. BMC Public Health 2010;10:258.
33. Baliunas DM, Taylor BM, Irving HM, et al. Alcohol as a risk factor for type 2 diabetes: a systematic review and meta-analysis. Diabetes Care 2009;32:2123.
34. Rehm J, Taylor B, Mohapatra S, et al. Alcohol as a risk factor for liver cirrhosis: a systematic review and meta-analysis. Drug Alcohol Rev 2010;29:437-45.
35. Corrao G, Bagnardi V, Zambon A, et al. A meta-analysis of alcohol consumption and the risk of 15 diseases. Prev Med 2004;38:613-19.
36. Forouzanfar MH, Alexander L, Anderson HR, et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015;386:2287-323.
37. Physical Activity Guidelines Advisory Committee. Physical Activity Guidelines Advisory Committee Report. Washington DC: U.S. Department of Health and Human Services, 2008.
38. Blondell SJ, Hammersley-Mather R, Veerman JL. Does physical activity prevent cognitive decline and dementia? A systematic review and meta-analysis of longitudinal studies. BMC Public Health 2014;14:510.
39. Fishman G. Monte Carlo: concepts, algorithms, and applications. New York: Springer-Verlag, 1995.
40. University of California Berkeley (USA), Max Planck Institute for Demographic Research (Germany). Human Mortality Database (2 April 2015). http://www.mortality.org
41. Max Planck Institute for Demographic Research (Germany), Vienna Institute of Demography (Austria). Human Fertility Database (29 April 2015). http://www.humanfertility.org
42. Hyndman RJ, Booth H, Yasmeen F. Coherent mortality forecasting: the product-ratio method with functional time series models. Demography 2013;50:261-83.
43. Salomon JA, Murray CJ. The epidemiologic transition revisited: compositional models for causes of death by age and sex. Popul Dev Rev 2002;28:205-28.
44. World Health Organization. WHO Mortality Database (4 November 2014). http://www.who.int/healthinfo/statistics/mortality-rawdata/en/
45. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006;3:e442.
46. Naghavi M, Makela S, Foreman K, et al. Research algorithms for enhancing public health utility of national causes-of-death data. Popul Health Metr 2010;8:9.
47. The World Bank. World Development Indicators (1 May 2015). http://data.worldbank.org/data-catalog/world-development-indicators
48. Greene WH. Econometric analysis. 5th edn. Upper Saddle River, NJ: Prentice Hall, 2003.
49. WHO. National health accounts: country health information. Geneva: World Health Organization, 2015 (15 December 2015). http://apps. who.int/nha/database/Country-Profile/Index/en
50. Donohue JM, Pincus HA. Reducing the societal burden of depression. Pharmacoeconomics 2007;25:7-24.
51. Luengo-Fernandez R, Leal J, Gray A. UK research spend in 2008 and 2012: comparing stroke, cancer, coronary heart disease and dementia. BMJ Open 2015;5:e006648.
52. Kingdon D. Health research funding: mental health research continues to be underfunded. BMJ 2006;332:1510.
53. Gustavsson A, Svensson M, Jacobi F, et al. Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 2011;21:718-79.
54. Cecchini M, Sassi F, Lauer JA, et al. Tackling of unhealthy diets, physical inactivity, and obesity: health effects and cost-effectiveness. Lancet 2010;376:1775-84.
55. Cobiac LJ, Vos T, Doran C, et al. Cost-effectiveness of interventions to prevent alcohol-related disease and injury in Australia. Addiction 2009;104:1646-55.
56. Cobiac LJ, Vos T, Veerman JL. Cost-effectiveness of interventions to reduce dietary salt intake. Heart 2010;96:1920-5.
57. Nghiem N, Blakely T, Cobiac LJ, et al. Health and economic impacts of eight different dietary salt reduction interventions. PLoS ONE 2015;10:e0123915.
58. Hall KD, Sacks G, Chandramohan D, et al. Quantification of the effect of energy imbalance on bodyweight. Lancet 2011;378:826-37.
59. Rosenzweig C, Jones J, Hatfield J, et al. The agricultural model intercomparison and improvement project (AgMIP): protocols and pilot studies. Agric For Meteorol 2013;170:166-82.
60. Wahid A, Manek N, Nichols M, et al. Quantifying the association between physical activity and cardiovascular disease and diabetes: a systematic review and meta-analysis, J Am Heart Assoc 2016;5: e002495.